Sorafenib versus Transarterial chemoembolization for advanced-stage hepatocellular carcinoma: a cost-effectiveness analysis
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Sorafenib versus Transarterial chemoembolization for advanced-stage hepatocellular carcinoma: a cost-effectiveness analysis
Authors
Keywords
Sorafenib, Transarterial chemoembolization, Advanced-stage hepatocellular carcinoma, Cost-effectiveness analysis, Markov model
Journal
BMC CANCER
Volume 18, Issue 1, Pages -
Publisher
Springer Nature
Online
2018-04-19
DOI
10.1186/s12885-018-4308-7
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cost-effectiveness of Stereotactic Body Radiation Therapy versus Radiofrequency Ablation for Hepatocellular Carcinoma: A Markov Modeling Study
- (2017) Erqi L. Pollom et al. RADIOLOGY
- Evidence-Based Diagnosis, Staging, and Treatment of Patients With Hepatocellular Carcinoma
- (2016) Jordi Bruix et al. GASTROENTEROLOGY
- Prospective Study of Transcatheter Arterial Chemoembolization (TACE) with Ginsenoside Rg3 versus TACE Alone for the Treatment of Patients with Advanced Hepatocellular Carcinoma
- (2016) Bo Zhou et al. RADIOLOGY
- Cost-effectiveness of community-based screening and treatment for chronic hepatitis B in The Gambia: an economic modelling analysis
- (2016) Shevanthi Nayagam et al. Lancet Global Health
- Global cancer statistics, 2012
- (2015) Lindsey A. Torre et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Cost-effectiveness of sorafenib as a first-line treatment for advanced hepatocellular carcinoma
- (2015) Pengfei Zhang et al. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
- Predictors of survival in patients with advanced hepatocellular carcinoma who permanently discontinued sorafenib
- (2015) Massimo Iavarone et al. HEPATOLOGY
- Comparison of Chemoembolization with and without Radiation Therapy and Sorafenib for Advanced Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis: A Propensity Score Analysis
- (2015) Gi-Ae Kim et al. JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY
- Determinants of Survival After Sorafenib Failure in Patients With BCLC-C Hepatocellular Carcinoma in Real-World Practice
- (2015) I-Cheng Lee et al. MEDICINE
- Prognosis of untreated hepatocellular carcinoma
- (2014) Edoardo G. Giannini et al. HEPATOLOGY
- Cost-effectiveness analysis of liver resection versus transplantation for early hepatocellular carcinoma within the Milan criteria
- (2014) Kheng Choon Lim et al. HEPATOLOGY
- Field practice study of half-dose sorafenib treatment on safety and efficacy for hepatocellular carcinoma: A propensity score analysis
- (2014) Manabu Morimoto et al. HEPATOLOGY RESEARCH
- Comparison of standard-dose and half-dose sorafenib therapy on clinical outcome in patients with unresectable hepatocellular carcinoma in field practice: A propensity score matching analysis
- (2014) HIROKI NISHIKAWA et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Sorafenib Combined with Transarterial Chemoembolization versus Transarterial Chemoembolization Alone for Advanced-Stage Hepatocellular Carcinoma: A Propensity Score Matching Study
- (2014) Hao Hu et al. PLoS One
- Cost-effectiveness of sorafenib treatment in field practice for patients with hepatocellular carcinoma
- (2013) Calogero Cammà et al. HEPATOLOGY
- Cost-effectiveness of hepatic resection versus percutaneous radiofrequency ablation for early hepatocellular carcinoma
- (2013) Alessandro Cucchetti et al. JOURNAL OF HEPATOLOGY
- Transcatheter Arterial Chemoembolization for Advanced Hepatocellular Carcinoma with Portal Vein Invasion: Safety, Efficacy, and Prognostic Factors
- (2013) Ming-Chih Chern et al. JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY
- The feasibility of combined transcatheter arterial chemoembolization and radiotherapy for advanced hepatocellular carcinoma
- (2013) Ju-Yeon Cho et al. LIVER INTERNATIONAL
- Efficacy and safety of sorafenib in patients with advanced hepatocellular carcinoma according to baseline status: Subset analyses of the phase III Sorafenib Asia–Pacific trial
- (2012) Ann-Lii Cheng et al. EUROPEAN JOURNAL OF CANCER
- Efficacy and safety of sorafenib in patients with advanced hepatocellular carcinoma: Subanalyses of a phase III trial
- (2012) Jordi Bruix et al. JOURNAL OF HEPATOLOGY
- The natural history of compensated HCV-related cirrhosis: A prospective long-term study
- (2012) Eduardo Vilar Gomez et al. JOURNAL OF HEPATOLOGY
- Hepatocellular carcinoma
- (2012) Alejandro Forner et al. LANCET
- Advanced-Stage Hepatocellular Carcinoma: Transarterial Chemoembolization versus Sorafenib
- (2012) Matthias Pinter et al. RADIOLOGY
- Comparison of the efficacy of transcatheter arterial chemoembolization and sorafenib for advanced hepatocellular carcinoma
- (2012) HIROKI NISHIKAWA et al. Experimental and Therapeutic Medicine
- Field-practice study of sorafenib therapy for hepatocellular carcinoma: A prospective multicenter study in Italy
- (2011) Massimo Iavarone et al. HEPATOLOGY
- Management of hepatocellular carcinoma: An update
- (2011) Jordi Bruix et al. HEPATOLOGY
- Survival of patients with advanced hepatocellular carcinoma: Sorafenib versus other treatments
- (2011) Hwi Young Kim et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- Transarterial Chemoembolization Can Be Safely Performed in Patients with Hepatocellular Carcinoma Invading the Main Portal Vein and May Improve the Overall Survival
- (2011) Goh Eun Chung et al. RADIOLOGY
- Transarterial Chemoembolization for Unresectable Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis: A Prospective Comparative Study
- (2010) Jun Luo et al. ANNALS OF SURGICAL ONCOLOGY
- Clinical outcome of 251 patients with extrahepatic metastasis at initial diagnosis of hepatocellular carcinoma: Does transarterial chemoembolization improve survival in these patients?
- (2010) Dong-Jun Yoo et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- Economic evaluation of sorafenib in unresectable hepatocellular carcinoma
- (2010) Brian I. Carr et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- Modified RECIST (mRECIST) Assessment for Hepatocellular Carcinoma
- (2010) Riccardo Lencioni et al. SEMINARS IN LIVER DISEASE
- Reappraisal of repeated transarterial chemoembolization in the treatment of hepatocellular carcinoma with portal vein invasion
- (2009) Kang Mo Kim et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- The Epidemiology of Newly Diagnosed Chronic Liver Disease in Gastroenterology Practices in the United States: Results From Population-Based Surveillance
- (2008) Beth P. Bell et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Economic evaluation of sorafenib in the treatment of hepatocellular carcinoma in Canada
- (2008) Noemi Muszbek et al. CURRENT MEDICAL RESEARCH AND OPINION
- Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial
- (2008) Ann-Lii Cheng et al. LANCET ONCOLOGY
- Sorafenib in Advanced Hepatocellular Carcinoma
- (2008) Josep M. Llovet et al. NEW ENGLAND JOURNAL OF MEDICINE
- Assessing cost-effectiveness in healthcare: history of the $50,000 per QALY threshold
- (2008) Scott D Grosse Expert Review of Pharmacoeconomics & Outcomes Research
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation